News Category: Health & Medical

–Results from ongoing testing and monitoring of COVID-19 variants shows the rapid microfluidic test detects Omicron at a comparable sensitivity to other variants LumiraDx (Nasdaq: LMDX), a next-generation point of care diagnostics company, today announced that results from ongoing testing and monitoring of COVID-19 variants show its SARS-CoV-2 Antigen test detects the Omicron Variant. In-house … Continued

PostEra, a biotechnology company specializing in machine learning for preclinical drug discovery, today announced $24M in equity financing to accelerate medicinal chemistry and bring new cures to patients. Logo – https://mma.prnewswire.com/media/1722598/PostEra_Logo.jpg PostEra will use the proceeds to advance a series of partnered drug discovery programs, initiate its own internal drug discovery, and further develop its … Continued

Cambrex recently celebrated the 40th anniversary of its founding in 1981. Following forty years of growth and transformation into a leading global contract development and manufacturing organization (CDMO), Cambrex continues its commitment to leadership in pharmaceutical drug substance manufacturing with over $100 million of investments in progress across its global manufacturing network. “As Cambrex celebrates … Continued

— New CEO Richard Hasz Salutes Region – the Most Generous in the Nation for 14 Consecutive Years – and Team of “Heroes” for Extraordinary Commitment Gift of Life Donor Program ( https://c212.net/c/link/?t=0&l=en&o=3408741-1&h=3867576698&u=https%3A%2F%2Fwww.donors1.org%2Fabout-gift-of-life%2Foverview%2F&a=Gift+of+Life+Donor+Program ) once again leads the nation among all 57 U.S. organ procurement organizations (OPO) in saving lives. For the 14th consecutive year, … Continued

Clario, a technology company that delivers the leading endpoint technology solutions for clinical trials, and XingImaging, a radiopharmaceutical production and positron emission tomography (PET) acquisition company, have expanded their partnership to deliver PET imaging clinical trials for testing novel therapeutics in China. Logo – https://mma.prnewswire.com/media/1677749/Clario_Logo.jpg Clario, formerly ERT and Bioclinica, and XingImaging joined forces in … Continued

Virtue Diagnostics, an innovative IVD company, has just announced closing US$100 million in Series B funding. Virtue Diagnostics, founded in 2019, is focused on clinical tests for China and emerging markets. Sequoia China and Morningside Ventures jointly led the investment round with ORIZA Holdings. Existing investors Lilly Asia Ventures and PerkinElmer Ventures participated while HAOYUE … Continued

DiscGenics ( https://c212.net/c/link/?t=0&l=en&o=3404974-1&h=3114304150&u=https%3A%2F%2Fwww.discgenics.com%2F&a=DiscGenics ), Inc., a privately held, clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, today announced that Chief Executive Officer and Chairman Flagg Flanagan will present at the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January … Continued

Cognivia today announced a new name for the company formerly known as Tools4Patient, which provides clinical trials solutions based on AI / ML that account for individual patient personality traits, beliefs and perceptions. The transition to Cognivia ( https://c212.net/c/link/?t=0&l=en&o=3403305-1&h=2344867879&u=https%3A%2F%2Fcognivia.com%2F&a=Cognivia ) more closely reflects the company’s mission to “quantify the power of the mind” and integrate … Continued

Vaccines have been a trending topic ever since the coronavirus outbreak two years ago. DreamTec Research Limited (DreamTec, http://www.dreamtec.hk) has its major breakthrough in developing a COVID-19 oral vaccine. In its recently published peer-reviewed paper in an international medical journal Vaccines(https://doi.org/10.3390/vaccines10010002), which demonstrates Bacillus subtilis (B. subtilis) spores, expressing a SARS-CoV-2 spike protein receptor binding … Continued

Joint research results from Biologics of Jemincare and Shanghai Institute of Materia Medica (SIMM) of Chinese Academy of Sciences (CAS) confirmed that JMB2002, an anti-SARS-CoV-2 neutralizing antibody (NAb) discovered by Biologics of Jemincare is still effective against Omicron variant of SARS-CoV-2. A team of scientists led by Dr. Su-Jun Deng from biologics of Jemincare R&D … Continued